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Materials and Methods.  Unless otherwise stated, reactions were performed in flame-
dried glassware under an argon or nitrogen atmosphere using dry deoxygenated solvents.  
Solvents were dried by passage through an activated alumina column under argon.  
Diphenylphosphine, di-p-tolylphosphine, dicyclohexylphosphine, and 
diisobutylphosphine were purchased from Strem Chemicals, Inc. and were used as 
received.  Copper (I) iodide, N,N′-dimethylethylenediamine, cesium carbonate, 2-
bromobenzoyl chloride, tetrafluoroboric acid solution and molecular sieves 4Å were 
purchased from Sigma-Aldrich Chemical Company and used as received.  Bis-(4-
(trifluoromethyl)phenyl)phosphine was prepared by the known method.1  (S)-Leucinol 
and (S)-tryptophanol were purchased from Sigma-Aldrich Chemical Company and 
Chem-Impex International, Inc., respectively.  The other starting chiral amino alcohols 
were prepared by the reduction of the corresponding amino acids,2 which were purchased 
from Chem-Impex International, Inc.  2-Bromo-5-methoxybenzoyl chloride and 2-
bromo-5-(trifluoromethyl)-benzoyl chloride were prepared from the corresponding 
benzoic acid derivatives.3  Reaction temperatures were controlled by an IKAmag 
temperature modulator.  Thin-layer chromatography (TLC) was performed using E. 
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized by UV fluorescence 
quenching, anisaldehyde, CAM, or KMnO4 staining.  ICN Silica gel (particle size 0.032-
0.063 mm) was used for flash chromatography.  Optical rotations were measured with a 
Jasco P-1010 polarimeter at 589 nm.  1H, 13C, 31P and 19F NMR spectra were recorded on 
a Varian Mercury 300 (at 300 MHz, 75 MHz, 121 MHz and 282 MHz, respectively).  
1H NMR spectra are reported relative to Me4Si (δ 0.0 ppm) or residual CHCl3?(δ 7.26 
ppm) or CHD2CN??δ 1.94 ppm).  Data for 1H NMR spectra are reported as follows:  
chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  Multiplicities 
are reported as follows:  s = singlet, d = doublet, t = triplet, q = quartet, sept. = septet, m 
= multiplet, comp. m = complex multiplet, app. = apparent, bs = broad singlet.  13C 
NMR were reported relative to CDCl3 (δ 77.0 ppm) and?CD3CN (δ 1.39 ppm), 
respectively.  19F NMR spectra were reported relative to CFCl3 (δ 0.0 ppm).  31P NMR 
spectra were reported relative to external H3PO4 (δ 0.0 ppm).  FTIR spectra were 
recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of 
absorption (cm-1).  High resolution mass spectra were obtained from the Caltech Mass 
Spectral Facility. 
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(S)-2-Bromo-N-(1-hydroxy-3,3-dimethylbutan-2-yl)benzamide (SI1).  To a solution 
of (S)-t-leucinol (3.57 g, 30.5 mmol, 1.0 equiv) in DCM (100 mL) was added a solution 
of Na2CO3 (9.70 g, 91.5 mmol, 3.0 equiv) in water (75.0 mL).  To the vigorously stirred 
biphasic mixture was added 2-bromobenzoyl chloride (4.58 mL, 35.1 mmol, 1.15 equiv) 
in a dropwise manner.  After 12 h at ambient temperature, the layers were separated, and 
the aqueous layer was extracted with DCM (2 x 50 mL).  The combined organics were 
treated with KOH (15 mL of a 1 M methanolic solution) for 15 min, neutralized with 3 M 
HCl, and water (50 mL) was added.  The layers were separated, and the aqueous layer 
extracted with DCM (2 x 50 mL).  The combined organics were dried (Na2SO4), 
evaporated, and the residue chromatographed (25 to 35% acetone in hexanes on SiO2) to 
give amide SI1 (8.19 g, 89.5% yield):  mp 50.0-51.0 °C from acetone/hexanes; 1H NMR 
(300 MHz, CDCl3) δ 7.58 (dd, J = 7.8, 0.9 Hz, 1H), 7.54 (dd, J = 7.5, 1.8 Hz, 1H), 7.34 
(app. dt, J = 7.4, 1.1 Hz, 1H), 7.26 (app. dt, J = 7.7, 1.8 Hz, 1H), 6.24 (bd, J = 8.1 Hz, 
1H), 4.05 (m, 1H), 3.93 (dd, J = 11.4, 3.6 Hz, 1H), 3.66 (dd, J = 11.4, 7.5 Hz, 1H), 2.68 
(bs, 1H), 1.03 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 168.7, 137.9, 133.3, 131.2, 129.7, 
127.6, 119.0, 62.9, 60.2, 33.8, 27.1; FTIR (Neat Film NaCl) 3245, 3070, 2963, 1640, 
1557 cm-1; HRMS (FAB, Pos.) m/z calc'd for C13H19NO2Br [M+H]+: 300.0599, found 
300.0590; [α]D29 +20.2 (c 2.38, methanol, >99 % ee). 
 
(S)-2-(2-Bromophenyl)-4-tert-butyl-4,5-dihydrooxazole4 (SI2).  A solution of amide 
SI1 (8.10 g, 27.0 mmol, 1.0 equiv), p-toluenesulfonyl chloride (6.69 g, 35.1 mmol, 1.3 
equiv), triethylamine (18.7 mL, 135.0 mmol, 5.0 equiv) in DCM (200 mL) in a round 
bottom flask equipped with a reflux condenser was heated at 55 °C for 22 h.  At which 
time, water (28 mL) was added and heating continued at 75 °C for 2 h.  The reaction 
mixture was cooled, the layers separated, and the aqueous layer extracted with DCM (2 x 
25 mL).  The combined organics were dried (Na2SO4), evaporated, and the residue 
chromatographed (5% EtOAc in hexanes on SiO2) to give phenyloxazoline SI2 (6.19 g, 
81.2% yield):  1H NMR (300 MHz, CDCl3) δ 7.64 (app. dt, J = 8.7, 1.7 Hz, 2H), 7.33 
(app. dt, J = 7.7, 1.5 Hz, 1H), 7.26 (m, 1H), 4.38 (dd, J = 10.5, 8.9 Hz, 1H), 4.25 (app. t, 
J = 8.3 Hz, 1H), 4.10 (dd, J = 10.2, 8.1 Hz, 1H), 1.00 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 162.8, 133.6, 131.4, 131.2, 130.2, 127.0, 121.8, 76.6, 69.0, 34.0, 25.9; FTIR (Neat Film 
NaCl) 2956, 1661, 1478, 1354, 1099, 1022, 963 cm-1; HRMS (FAB Pos.) m/z calc'd for 
C13H17NOBr [M+H]+: 282.0493, found 282.0488; [α]D29 -48.3 (c 3.77, hexane, >99 % ee). 
 
The following aryl bromides were synthesized from the corresponding chiral amino 
alcohols and 2-bromobenzoyl chlorides by the same manner as described above.  
 






(R)-2-(2-Bromophenyl)-4-cyclohexyl-4,5-dihydrooxazole.  White powder; mp 132-
134 ºC; Rf = 0.50 (hexanes/EtOAc, 4/1); 1H NMR (300 MHz, CDCl3) δ 7.67 (dd, J = 7.4, 
1.9 Hz, 1H), 7.63 (dd, J = 7.7, 1.4 Hz, 1H), 7.33 (td, J = 7.4, 1.4 Hz, 1H), 7.27 (td, J = 7.7, 
2.2 Hz, 1H), 5.44 (m, 1H), 4.17 (m, 2H), 1.97 (d, J = 12.7 Hz, 1H), 1.73 (m, 4H), 1.58 (m, 
1H), 1.17 (m, 5H); 13C NMR (75 MHz, CDCl3) δ 163.0, 133.9, 131.6, 131.5, 127.2, 121.9, 
72.3, 70.7, 42.8, 29.6, 29.0, 26.7, 26.3; FTIR (Neat Film NaCl) 2924, 1640, 1537, 1468, 
1328, 1057, 1026 cm-1; HRMS (EI) m/z calc’d for C15H18NOBr [M+]: 307.0572, found 






(S)-4-(1-Adamantyl)-2-(2-bromophenyl)-4,5-dihydrooxazole.  White wax; Rf = 0.43 
(hexanes/Et2O, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.68-7.60 (m, 2H), 7.36-7.23 (m, 2H), 
4.39-4.26 (m, 2H), 3.94 (m, 1H), 2.01 (m, 3H), 1.80-1.63 (m, 10H), 1.58-1.50 (m, 2H); 
13C NMR (75 MHz, CDCl3) δ 162.6, 133.7, 131.4, 131.3, 130.3, 127.0, 121.8, 76.8, 67.5, 
38.6, 37.1, 35.7, 28.2; FTIR (Neat Film NaCl) 2902, 2848, 1659, 1591, 1478, 1449, 1346, 
1308, 1246, 1095, 1022, 960, 764, 731 cm-1; HRMS (FAB, Pos.) m/z calc’d for 






(S)-2-(2-Bromophenyl)-4-neopentyl-4,5-dihydrooxazole.  Colorless oil; Rf = 0.48 
(hexanes/Et2O, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.67 (dd, J = 7.8, 1.5 Hz, 1H), 7.62 
(dd, J = 7.8, 1.5 Hz, 1H), 7.32 (td, J = 7.8, 1.5 Hz, 1H), 7.26 (td, J = 7.8, 1.5 Hz, 1H), 
4.57 (dd, J = 9.3, 8.1 Hz, 1H), 4.35 (m, 1H), 3.99 (t, J = 8.1 Hz, 1H), 1.92 (dd, J = 13.8, 
4.8 Hz, 1H), 1.47 (dd, J = 13.8, 7.8 Hz, 1H), 1.00 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 162.3, 133.7, 131.5, 131.3, 130.0, 127.0, 121.8, 74.5, 64.5, 50.5, 30.3, 30.0; 
FTIR (Neat Film NaCl) 2955, 1654, 1592, 1475, 1431, 1356, 1244, 1093, 1026, 966, 765, 
730 cm-1; HRMS (FAB, Pos.) m/z calc’d for C14H19BrNO [M+H]+: 296.0650, found 
296.0660; [α]26D = -47.7 (c 1.04, CHCl3). 







(S)-4-(2-(Benzyloxy)propan-2-yl)-2-(2-bromophenyl)-4,5-dihydrooxazole.  White 
solid; mp 54-56 ºC; Rf = 0.26 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.69-
7.62 (m, 2H), 7.37-7.24 (m, 7H), 4.65-4.39 (m, 5H), 1.49 (s, 3H), 1.31 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 164.0, 139.4, 133.7, 131.6, 131.3, 130.0, 128.3, 127.2, 127.14, 
127.07, 121.8, 77.0, 75.1, 69.2, 64.0, 24.0, 20.1; FTIR (Neat Film NaCl) 3064, 3031, 
2975, 2906, 1654, 1590, 1474, 1454, 1435, 1386, 1354, 1244, 1155, 1100, 1064, 1027, 
960, 735 cm-1; HRMS (FAB, Pos.) m/z calc’d for C19H21BrNO2 [M+H]+: 374.0756, found 







dihydrooxazole.  Colorless oil; Rf = 0.52 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, 
CDCl3) δ 7.67 (dd, J = 7.5, 2.1 Hz, 1H), 7.62 (dd, J = 7.5, 1.2 Hz, 1H), 7.32 (td, J = 7.5, 
1.2 Hz, 1H), 7.26 (td, J = 7.5, 2.1 Hz, 1H), 4.52 (dd, J = 8.4, 7.2 Hz, 1H), 4.39 (dd, J = 
10.2, 8.4 Hz, 1H), 4.22 (dd, J = 10.2, 7.2 Hz, 1H), 1.39 (s, 3H), 1.29 (s, 3H), 0.84 (s, 9H), 
0.114 (s, 3H), 0.111 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 163.7, 133.8, 131.5, 131.3, 
130.0, 127.0, 121.8, 77.0, 74.8, 69.3, 28.8, 25.7, 24.7, 18.0, -2.1, -2.2; FTIR (Neat Film 
NaCl) 2956, 2929, 2856, 1656, 1591, 1472, 1435, 1381, 1355, 1253, 1187, 1162, 1101, 
1053, 835, 773 cm-1; HRMS (FAB, Pos.) m/z calc’d for C18H29BrNO2Si [M+H]+: 






(S)-2-(2-Bromophenyl)-4-(naphthalen-1-ylmethyl)-4,5-dihydrooxazole.  Colorless 
oil; Rf = 0.44 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 8.18 (d, J = 8.4 Hz, 
1H), 7.88 (m, 1H), 7.78 (dd, J = 7.2, 2.4 Hz, 1H), 7.70-7.64 (m, 2H), 7.60-7.26 (m, 6H), 
4.84 (m, 1H), 4.36-4.23 (m, 2H), 3.84 (dd, J = 14.1, 4.8 Hz, 1H), 3.12 (dd, J = 14.1, 9.3 
Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 163.5, 134.0, 133.80, 133.76, 132.0, 131.6, 131.3, 
129.9, 128,8, 127.5, 127.1, 127.0, 126.1, 125.7, 125.4, 123.8, 121.8, 72.2, 67.2, 38.9; 
FTIR (Neat Film NaCl) 3057, 1653, 1590, 1476, 1430, 1355, 1087, 1024, 960, 780, 729 
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cm-1; HRMS (FAB, Pos.) m/z calc’d for C20H17BrNO [M+H]+: 366.0493, found 366.0471; 






(S)-2-(2-Bromophenyl)-4-(naphthalen-2-ylmethyl)-4,5-dihydrooxazole.  Colorless 
oil; Rf = 0.37 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.84-7.78 (m, 3H), 
7.73 (br s, 1H), 7.68-7.63 (m, 2H), 7.51-7.41 (m, 3H), 7.37-7.28 (m, 2H), 4.75 (m, 1H), 
4.39 (dd, J = 9.3, 8.4 Hz, 1H), 4.24 (dd, J = 8.4, 7.5 Hz, 1H), 3.42 (dd, J = 13.8, 5.1 Hz, 
1H), 2.99 (dd, J = 13.8, 8.4 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 163.4, 135.2, 133.8, 
133.5, 132.3, 131.6, 131.2, 129.8, 128.2, 127.74, 127.70, 127.6, 127.5, 127.0, 126.0, 
125.5, 121.8, 71.9, 68.1, 41.7; FTIR (Neat Film NaCl) 3054, 2896, 1650, 1590, 1508, 
1477, 1431, 1356, 1244, 1097, 1024, 962, 818, 756, 729 cm-1; HRMS (FAB, Pos.) m/z 






(S)-2-(2-Bromophenyl)-4-phenethyl-4,5-dihydrooxazole.  Colorless oil; Rf = 0.43 
(hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.70-7.62 (m, 2H), 7.38-7.17 (m, 
7H), 4.50 (dd, J = 9.3, 8.1 Hz, 1H), 4.36 (m, 1H), 4.08 (t, J = 8.1 Hz, 1H), 2.94-2.74 (m, 
2H), 2.09 (m, 1H), 1.94 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 163.0, 141.6, 133.7, 
131.5, 131.2, 130.0, 128.43, 128.40, 127.1, 125.9, 121.8, 72.6, 66.5, 37.6, 32.2; FTIR 
(Neat Film NaCl) 2924, 1653, 1590, 1476, 1430, 1355, 1096, 1024, 962, 764, 730, 700 
cm-1; HRMS (FAB, Pos.) m/z calc’d for C17H17BrNO [M+H]+: 330.0493, found 330.0480; 






(S)-2-(2-Bromophenyl)-4-(2-methylbenzyl)-4,5-dihydrooxazole.  White solid; mp 53-
55 ºC; Rf = 0.43 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.70 (dd, J = 7.5, 
2.1 Hz, 1H), 7.65 (dd, J = 7.5, 1.2 Hz, 1H), 7.35 (td, J = 7.5, 1.2 Hz, 1H), 7.30 (td, J = 7.5, 
2.1 Hz, 1H), 7.25-7.14 (m, 4H), 4.66 (m, 1H), 4.41 (t, J = 8.7 Hz, 1H), 4.21 (dd, J = 8.7, 
7.5 Hz, 1H), 3.29 (dd, J = 14.1, 5.4 Hz, 1H), 2.79 (dd, J = 14.1, 9.0 Hz, 1H), 2.40 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 163.3, 136.4, 136.1, 133.7, 131.5, 131.2, 130.4, 129.8, 
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129.5, 127.0, 126.6, 126.0, 121.7, 72.1, 66.9, 38.9, 19.7; FTIR (Neat Film NaCl) 2954, 
1653, 1590, 1476, 1436, 1355, 1244, 1097, 1025, 962, 765, 730 cm-1; HRMS (FAB, Pos.) 








(S)-2-(2-Bromophenyl)-4-(2-(trifluoromethyl)benzyl)-4,5-dihydrooxazole.  Colorless 
oil; Rf = 0.52 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.72-7.63 (m, 3H), 
7.59 (m, 1H), 7.51 (m, 1H), 7.39-7.26 (m, 3H), 4.68 (m, 1H), 4.50 (t, J = 8.4 Hz, 1H), 
4.15 (t, J = 8.4 Hz, 1H), 3.27 (dd, J = 14.7, 7.2 Hz, 1H), 3.12 (ddd, J = 14.7, 6.3, 1.2 Hz, 
1H); 13C NMR (75 MHz, CDCl3) δ 163.5, 136.6 (q, JCF = 1 Hz), 133.7, 132.1, 131.8, 
131.7, 131.2, 129.7, 128.8 (q, JCF = 29 Hz), 127.1, 126.6, 126.0 (q, JCF = 6 Hz), 124.5 (q, 
JCF = 272 Hz), 121.8, 72.1, 67.5, 38.1 (q, JCF = 1 Hz); FTIR (Neat Film NaCl) 3068, 2897, 
1653, 1591, 1478, 1457, 1432, 1357, 1314, 1161, 1117, 1061, 1040, 964, 766, 730, 654 
cm-1; HRMS (FAB, Pos.) m/z calc’d for C17H14BrF3NO [M+H]+: 384.0211, found 







(R)-4-Benzhydryl-2-(2-bromophenyl)-4,5-dihydrooxazole.  White solid; mp 73-74 
ºC; Rf = 0.52 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.62-7.55 (m, 2H), 
7.39-7.15 (m, 12H), 5.18 (m, 1H), 4.49 (t, J = 6.0 Hz, 1H), 4.22-4.12 (m, 2H); 13C NMR 
(75 MHz, CDCl3) δ 163.6, 142.0, 141.8, 133.6, 131.5, 131.3, 129.9, 128.70, 128.67, 
128.4, 127.0, 126.8, 126.5, 121.9, 71.5, 70.5, 56.7; FTIR (Neat Film NaCl) 3026, 1654, 
1559, 1540, 1496, 1474, 1450, 1356, 1097, 1024, 963, 701 cm-1; HRMS (FAB, Pos.) m/z 









(R)-2-(2-Bromophenyl)-4-(3,5-di-tert-butylbenzyl)-4,5-dihydrooxazole.  Colorless 
oil; Rf = 0.57 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.69 (dd, J = 7.5, 2.1 
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Hz, 1H), 7.65 (dd, J = 7.5, 1.5 Hz, 1H), 7.38-7.28 (m, 3H), 7.10 (d, J = 1.8 Hz, 2H), 4.64 
(m, 1H), 4.39 (t, J = 8.4 Hz, 1H), 4.22 (dd, J = 8.4, 7.2 Hz, 1H), 3.27 (dd, J = 13.5, 4.8 
Hz, 1H), 2.77 (dd, J = 13.5, 9.0 Hz, 1H), 1.34 (s, 18H); 13C NMR (75 MHz, 
CDCl3) δ 163.1, 150.8, 136.8, 133.8, 131.5, 131.3, 129.7, 127.0, 123.4, 121.8, 120.5, 72.0, 
68.4, 42.1, 34.7, 31.4; FTIR (Neat Film NaCl) 2963, 1654, 1598, 1476, 1362, 1247, 1098, 
1023, 964 cm-1; HRMS (FAB, Pos.) m/z calc’d for C24H31BrNO [M+H]+: 428.1589, found 






(S)-4-(Benzo[b]thiophen-3-ylmethyl)-2-(2-bromophenyl)-4,5-dihydrooxazole.  Pale 
yellow oil; Rf = 0.45 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.90-7.84 (m, 
2H), 7.67-7.63 (m, 2H), 7.45-7.26 (m, 5H), 4.81 (m, 1H), 4.44 (dd, J = 9.3, 8.7 Hz, 1H), 
4.22 (dd, J = 8.7, 7.2 Hz, 1H), 3.46 (ddd, J = 14.7, 4.8, 1.2 Hz, 1H), 3.06 (ddd, J = 14.7, 
8.4, 0.9 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 163.5, 140.4, 138.9, 133.8, 132.3, 131.7, 
131.3, 129.7, 127.1, 124.3, 124.0, 123.1, 122.9, 121.8, 121.7, 72.3, 66.5, 34.4; FTIR 
(Neat Film NaCl) 3067, 2895, 1653, 1590, 1476, 1427, 1357, 1314, 1287, 1250, 1095, 
1022, 961, 758, 728 cm-1; HRMS (FAB, Pos.) m/z calc’d for C18H15BrNOS [M+H]+: 






(S)-4-((1H-Indol-3-yl)methyl)-2-(2-bromophenyl)-4,5-dihydrooxazole.  Pale yellow 
powder; mp 143-145 ºC; Rf = 0.17 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, 
CDCl3) δ 8.20 (br s, 1H), 7.72-7.62 (m, 3H), 7.38-7.06 (m, 6H), 4.77 (m, 1H), 4.39 (dd, J 
= 9.3, 8.7 Hz, 1H), 4.22 (dd, J = 8.7, 7.5 Hz, 1H), 3.39 (ddd, J = 14.7, 5.1, 1.2 Hz, 1H), 
2.97 (dd, J = 14.7, 8.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 163.3, 136.2, 133.7, 131.6, 
131.3, 129.9, 127.6, 127.1, 122.5, 122.1, 121.8, 119.4, 118.8, 111.8, 111.1, 72.4, 67.3, 
31.2; FTIR (Neat Film NaCl) 3413, 3217, 3057, 2923, 1652, 1590, 1477, 1456, 1433, 
1358, 1243, 1099, 1025, 957, 743 cm-1; HRMS (FAB, Pos.) m/z calc’d for C18H16BrN2O 
















(S)-2-(2-Bromo-5-methoxyphenyl)-4-tert-butyl-4,5-dihydrooxazole.  White powder; 
mp 41-43 ºC; Rf = 0.52 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.50 (d, J = 
9.0 Hz, 1H), 7.19 (d, J = 3.0 Hz, 1H), 6.84 (dd, J = 9.0, 3.0 Hz, 1H), 4.38 (dd, J = 10.2, 
8.7 Hz, 1H), 4.26 (t, J = 8.3 Hz, 1H), 4.10 (dd, J = 10.2, 8.1 Hz, 1H), 3.81 (s, 3H), 1.00 (s, 
9H); 13C NMR (75 MHz, CDCl3) δ 162.6, 158.5, 134.4, 130.7, 117.9, 116.1, 112.1, 76.6, 
69.0, 55.6, 34.0, 25.9; FTIR (Neat Film NaCl) 2957, 1662, 1594, 1571, 1476, 1410, 1364, 
1336, 1290, 1224, 1181, 1102, 1040, 1016, 969, 816 cm-1; HRMS (EI) m/z calc’d for 







(S)-2-(2-Bromo-5-(trifluoromethyl)phenyl)-4-tert-butyl-4,5-dihydrooxazole.  White 
powder; mp 32-33 ºC; Rf = 0.42 (hexanes/Et2O, 9/1); 1H NMR (300 MHz, CDCl3) δ 7.93 
(d, J = 2.4 Hz, 1H), 7.78 (d, J = 8.4 Hz, 1H), 7.52 (dd, J = 8.4, 2.4 Hz, 1H), 4.42 (dd, J = 
10.2, 9.0 Hz, 1H), 4.29 (t, J = 8.3 Hz, 1H), 4.14 (dd, J = 10.2, 8.1 Hz, 1H), 1.01 (s, 9H); 
13C NMR (75 MHz, CDCl3) δ 161.5, 134.5, 130.9, 129.8 (q, JCF = 33 Hz), 128.2 (q, JCF = 
4 Hz), 127.9 (q, JCF = 4 Hz), 125.9 (q, JCF = 1 Hz), 123.4 (q, JCF = 271 Hz), 76.9, 69.2, 
34.0, 25.9; FTIR (Neat Film NaCl) 2959, 1662, 1607, 1479, 1341, 1325, 1298, 1262, 
1242, 1174, 1134, 1082, 1028, 966, 912, 830 cm-1; HRMS (EI) m/z calc’d for 
C14H15BrF3NO [M+]: 349.0289, found 349.0299; [α]25D = -64.7 (c 1.26, CHCl3). 
 
 

















PHOX).  A mixture of copper(I) iodide (338.3 mg, 1.77 mmol, 0.125 equiv), 
diphenylphosphine (4.64 mL, 26.7 mmol, 1.88 equiv), N,N'-dimethylethylenediamine 
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(1.32 mL, 12.4 mmol, 0.875 equiv) in toluene (60 mL) was stirred for 20 min at ambient 
temperature.  At which point, phenyloxazoline SI2 (4.00 g, 14.2 mmol, 1.00 equiv), 
cesium carbonate (17.4 g, 53.3 mmol, 3.75 equiv), and toluene (60 mL) were added, the 
flask sealed and heated to 110 °C with stirring.  After 6 h, the reaction mixture was 
allowed to cool to ambient temperature, filtered, and the filter cake was washed with 
DCM (2 x 50 mL).  Evaporation of the solvent and chromatography (3 to 7 % Et2O in 
hexanes on SiO2) afforded the known5 (S)-t-Bu-PHOX (4.48 g, 81 % yield). 
 
The following PHOX derivatives were synthesized from the corresponding aryl bromides 






(R)-4-Cyclohexyl-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole.  White 
solid; mp 122-124 ºC; Rf = 0.57 (hexanes/EtOAc, 4/1); 1H NMR (300 MHz, 
CDCl3) δ 7.87 (ddd, J = 7.7, 4.1, 1.7 Hz, 1H), 7.27 (m, 13H), 6.82 (ddd, J = 7.7, 4.1, 1.1 
Hz, 1H), 4.12 (ddd, J = 14.6, 9.1, 1.4 Hz, 1H), 3.85 (t, J = 8.3 Hz, 1H), 3.81 (t, J = 8.5 Hz, 
1H), 1.60 (m, 4H), 1.28 (d, J = 13.5 Hz, 1H), 1.05 (m, 4H), 0.80 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 162.7 (d, JCP = 3 Hz), 138.0-139.0 (6 lines), 134.5 (d, JCP = 21 Hz), 133.8, 
133.7 (d, JCP = 20 Hz), 131.8 (d, JCP = 19 Hz), 130.4, 129.8 (d, JCP = 3 Hz), 128.6-128.0 
(7 lines), 71.2, 70.1, 42.7, 29.4, 29.0, 26.4, 26.1, 26.0; 31P NMR (121 MHz, CDCl3) δ -
4.21; FTIR (Neat Film NaCl) 3053, 2923, 2852, 1651, 1478, 1434, 1356, 1089, 1044, 964, 
908 cm-1; HRMS (EI) m/z calc’d for C27H28NOP [M+]: 413.1909, found 413.1923; [α]25D 






(S)-4-(1-Adamantyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole.  White 
solid; mp 163-164 ºC; Rf = 0.59 (hexanes/EtOAc, 5/1); 1H NMR (300 MHz, 
CDCl3) δ 7.93 (m, 1H), 7.40-7.20 (m, 12H), 6.85 (m, 1H), 4.11 (t, J = 9.0 Hz, 1H), 4.03 (t, 
J = 9.0 Hz, 1H), 3.73 (t, J = 9.0 Hz, 1H), 1.85 (m, 3H), 1.68-1.46 (m, 6H), 1.44-1.34 (m, 
3H), 1.24-1.14 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 162.4 (d, JCP = 3 Hz), 138.8-138.3 
(6 lines), 134.4 (d, JCP = 21 Hz), 134.1, 133.4 (d, JCP = 20 Hz), 132.0 (d, JCP = 20 Hz), 
130.3, 129.7 (d, JCP = 3 Hz), 128.5-128.0 (7 lines), 76.8, 66.8, 38.2, 37.0, 35.3, 28.1; 31P 
NMR (121 MHz, CDCl3) δ -5.67; FTIR (Neat Film NaCl) 3053, 2902, 2848, 1651, 1586, 
1477, 1434, 1346, 1248, 1089, 1044, 1026, 963, 744, 696 cm-1; HRMS (FAB, Pos.) m/z 
calc’d for C31H33NOP [M+H]+: 466.2300, found 466.2309; [α]27D = -31.8 (c 0.48, CHCl3). 







(S)-2-(2-(Diphenylphosphino)phenyl)-4-neopentyl-4,5-dihydrooxazole.  White solid; 
mp 83-86 ºC; Rf = 0.52 (hexanes/EtOAc, 5/1); 1H NMR (300 MHz, CDCl3) δ 7.85 (ddd, J 
= 7.8, 3.6, 1.5 Hz, 1H), 7.38-7.23 (m, 12H), 6.84 (ddd, J = 7.8, 4.5, 1.5 Hz, 1H), 4.25 (dd, 
J = 9.3, 8.1 Hz, 1H), 4.03 (m, 1H), 3.58 (t, J = 8.1 Hz, 1H), 1.52 (dd, J = 14.1, 4.5 Hz, 
1H), 0.93 (dd, J = 14.1, 8.1 Hz, 1H), 0.84 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 163.0 (d, 
JCP = 3 Hz), 138.7 (d, JCP = 25 Hz), 137.9 (d, JCP = 12 Hz), 137.8 (d, JCP = 10 Hz), 134.3 
(d, JCP = 21 Hz), 133.9 (d, JCP = 21 Hz), 133.5 (d, JCP = 2 Hz), 131.8 (d, JCP = 18 Hz), 
130.3, 129.8 (d, JCP = 3 Hz), 128.6-128.3 (6 lines), 127.9, 73.9, 64.0, 49.7, 30.0, 29.8; 31P 
NMR (121 MHz, CDCl3) δ -3.95; FTIR (Neat Film NaCl) 3054, 2955, 1652, 1586, 1476, 
1434, 1355, 1248, 1089, 1035, 968, 742, 697 cm-1; HRMS (FAB, Pos.) m/z calc’d for 







dihydrooxazole.  Colorless viscous oil; Rf = 0.45 (hexanes/EtOAc, 5/1); 1H NMR (300 
MHz, CDCl3) δ 7.95 (ddd, J = 7.5, 3.6, 1.2 Hz, 1H), 7.41-7.19 (m, 17H), 6.88 (ddd, J = 
7.5, 4.2, 0.9 Hz, 1H), 4.43-4.23 (m, 4H), 4.15 (dd, J = 9.6, 7.8 Hz, 1H), 1.21 (s, 3H), 0.88 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 163.8 (d, JCP = 3 Hz), 139.5, 139.1-138.3 (5 lines), 
134.4 (d, JCP = 21 Hz), 134.2, 133.5 (d, JCP = 20 Hz), 131.6 (d, JCP = 19 Hz), 130.5, 129.9 
(d, JCP = 3 Hz), 128.6-128.1 (6 lines), 127.14, 127.12, 76.9, 74.9, 68.5, 63.9, 23.9, 19.5; 
31P NMR (121 MHz, CDCl3) δ -5.51; FTIR (Neat Film NaCl) 3067, 2973, 2905, 1649, 
1586, 1478, 1434, 1352, 1248, 1155, 1091, 1065, 1027, 964, 743, 697 cm-1; HRMS (FAB, 








4,5-dihydrooxazole.  White solid; mp 104-106 ºC; Rf = 0.62 (hexanes/EtOAc, 5/1); 1H 
NMR (300 MHz, CDCl3) δ 7.92 (ddd, J = 7.5, 3.6, 1.2 Hz, 1H), 7.40-7.20 (m, 12H), 6.88 
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(ddd, J = 7.5, 3.9, 0.9 Hz, 1H), 4.32 (dd, J = 7.5, 6.6 Hz, 1H), 4.09 (dd, J = 10.2, 7.5 Hz, 
1H), 4.02 (dd, J = 10.2, 6.6 Hz, 1H), 1.15 (s, 3H), 0.86 (s, 3H), 0.78 (s, 9H), 0.03 (s, 3H), 
0.01 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 163.6, 139.0-138.3 (6 lines), 134.3 (d, JCP = 
21 Hz), 134.2, 133.5 (d, JCP = 20 Hz), 131.9 (d, JCP = 19 Hz), 130.4, 129.8 (d, JCP = 3 Hz), 
128.5-128.0 (5 lines), 76.8, 74.9, 68.7, 28.7, 25.7, 23.9, 17.9, -2.2, -2.3; 31P NMR (121 
MHz, CDCl3) δ -5.99; FTIR (Neat Film NaCl) 3054, 2955, 2929, 2856, 1652, 1586, 1472, 
1434, 1353, 1251, 1162, 1091, 1058, 835, 774, 743, 696 cm-1; HRMS (FAB, Pos.) m/z 








White amorphous solid; Rf = 0.29 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, 
CDCl3) δ 8.00 (m, 1H), 7.91 (m, 1H), 7.85 (m, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.56-7.45 
(m, 2H), 7.42-7.28 (m, 13H), 7.16 (m, 1H), 6.87 (m, 1H), 4.55 (m, 1H), 3.97 (t, J = 8.4 
Hz, 1H), 3.86 (dd, J = 8.4, 7.2 Hz, 1H), 3.44 (dd, J = 14.4, 4.2 Hz, 1H), 2.39 (dd, J = 14.4, 
10.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 164.1 (d, JCP = 3 Hz), 138.9 (d, JCP = 25 Hz), 
137.84 (d, JCP = 10 Hz), 137.79 (d, JCP = 12 Hz), 134.5 (d, JCP = 21 Hz), 134.0, 133.82 (d, 
JCP = 21 Hz), 133.80, 133.5 (d, JCP = 3 Hz), 131.9, 131.3 (d, JCP =17 Hz), 130.6, 130.0 (d, 
JCP =3 Hz), 128.8-128.4 (6 lines), 127.9, 127.2, 126.6, 126.0, 125.6, 125.4, 123.8, 71.7, 
66.7, 38.2; 31P NMR (121 MHz, CDCl3) δ -3.59; FTIR (Neat Film NaCl) 3052, 2962, 
1651, 1585, 1511, 1476, 1434, 1354, 1216, 1089, 1037, 963, 745, 697 cm-1; HRMS (FAB, 








White amorphous solid; Rf = 0.24 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, 
CDCl3) δ 7.88 (m, 1H), 7.82-7.72 (m, 3H), 7.53 (br s, 1H), 7.49-7.27 (m, 14H), 7.23 (m, 
1H), 6.88 (m, 1H), 4.46 (m, 1H), 4.05 (dd, J = 9.0, 8.7 Hz, 1H), 3.83 (dd, J = 9.0, 7.5 Hz, 
1H), 3.08 (dd, J = 14.1, 5.1 Hz, 1H), 2.30 (dd, J = 14.1, 9.3 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 164.0 (d, JCP = 3?Hz), 138.9 (d, JCP = 25 Hz), 137.0-137.7 (3 lines), 135.6, 
134.4 (d, JCP = 21?Hz), 133.8 (d, JCP = 21 Hz), 133.5 (d, JCP = 2 Hz), 133.4, 132.1, 131.4 
(d, JCP = 18 Hz), 130.5, 129.9 (d, JCP = 3 Hz), 128.7-127.4 (12 lines), 125.9, 125.4, 71.4, 
67.7, 41.2; 31P NMR (121 MHz, CDCl3) δ -4.05; FTIR (Neat Film NaCl) 3052, 1651, 
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1508, 1476, 1434, 1354, 1217, 1090, 1027, 964, 817, 743, 697 cm-1; HRMS (FAB, Pos.) 







(S)-2-(2-(Diphenylphosphino)phenyl)-4-phenethyl-4,5-dihydrooxazole.  Colorless 
viscous oil; Rf = 0.38 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.89 (ddd, J = 
7.5, 3.6, 1.5 Hz, 1H), 7.40-7.14 (m, 15H), 7.11-7.07 (m, 2H), 6.87 (ddd, J = 7.5, 4.2, 1.5 
Hz, 1H), 4.22 (dd, J = 9.6, 8.1 Hz, 1H), 4.08 (m, 1H), 3.71 (t, J = 8.1 Hz, 1H), 2.66-2.45 
(m, 2H), 1.72-1.46 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 163.0 (d, JCP = 2 Hz), 141.8, 
138.7 (d, JCP = 25 Hz), 138.1 (d, JCP = 12Hz), 138.0 (d, JCP = 10 Hz), 134.2 (d, JCP = 21 
Hz), 133.73 (d, JCP = 1 Hz), 133.69 (d, JCP = 20 Hz), 131.7 (d, JCP = 19 Hz), 130.4, 129.7 
(d, JCP = 3 Hz), 128.5-128.1 (6 lines), 127.9,125.6, 72.0, 66.3, 37.2, 32.1; 31P NMR (121 
MHz, CDCl3) δ -4.55; FTIR (Neat Film NaCl) 3055, 2926, 1652, 1602, 1585, 1495, 1476, 
1454, 1434, 1355, 1308, 1251, 1217, 1134, 1090, 1036, 968, 743, 696 cm-1; HRMS (FAB, 








Colorless viscous oil; Rf = 0.33 (hexanes/Et2O, 3/1); 1H NMR (300 MHz, CDCl3) δ 7.89 
(m, 1H), 7.40-7.26 (m, 12H), 7.14-7.06 (m, 3H), 7.00-6.95 (m, 1H), 6.86 (m, 1H), 4.35 
(m, 1H), 4.06 (t, J = 8.4 Hz, 1H), 3.79 (dd, J = 8.4, 7.5 Hz, 1H), 2.91 (dd, J = 14.1, 5.1 
Hz, 1H), 2.26 (s, 3H), 2.10 (dd, J = 14.1, 9.6 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 163.8 (d, JCP = 3 Hz), 138.9 (d, JCP = 25 Hz), 137.9-137.7 (3 lines), 136.4, 134.4 
(d, JCP = 21 Hz), 133.8 (d, JCP = 21 Hz), 133.5 (d, JCP = 3Hz), 131.4 (d, JCP = 18 Hz), 
130.5, 130.3, 129.9 (d, JCP = 3 Hz), 129.2, 128.7-128.3 (5 lines), 127.9, 126.4, 125.9, 71.6, 
66.4, 38.4, 19.6; 31P NMR (121 MHz, CDCl3) δ -3.77; FTIR (Neat Film NaCl) 3052, 
1649, 1477, 1434, 1354, 1090, 1027, 964, 741, 697 cm-1; HRMS (FAB, Pos.) m/z calc’d 
















dihydrooxazole.  Colorless viscous oil; Rf = 0.48 (hexanes/EtOAc, 5/1); 1H NMR (300 
MHz, CDCl3) δ 7.89 (ddd, J = 7.5, 3.6, 1.2 Hz, 1H), 7.60 (d, J = 7.8 Hz, 1H), 7.45-7.27 
(m, 15H), 6.88 (ddd, J = 7.5, 3.9, 1.2 Hz, 1H), 4.39 (m, 1H), 4.19 (dd, J = 9.3, 8.4 Hz, 
1H), 3.79 (t, J = 8.4 Hz, 1H), 2.89 (dd, J = 14.7, 7.2 Hz, 1H), 2.64 (ddd, J = 14.7, 6.3, 0.9 
Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 163.8 (d, JCP = 3 Hz), 138.9 (d, JCP = 25 Hz), 
137.9 (d, JCP = 12Hz), 137.8 (d, JCP = 10Hz), 137.0, 134.3 (d, JCP = 21 Hz), 133.72 (d, JCP 
= 20 Hz), 133.66 (d, JCP = 2 Hz), 131.8, 131.7, 131.5 (d, JCP = 19 Hz), 130.6, 129.9 (d, JCP 
= 3 Hz), 128.7-128.3 (6 lines), 128.0, 126.3, 125.8 (q, JCF = 6 Hz), 124.5 (q, JCF = 273 
Hz), 71.6, 67.3, 37.5; 31P NMR (121 MHz, CDCl3) δ -4.64; 19F NMR (282 MHz, 
CDCl3) δ -59.76; FTIR (Neat Film NaCl) 3067, 1648, 1608, 1584, 1477, 1434, 1356, 
1313, 1161, 1117, 1038, 742, 696 cm-1; HRMS (FAB, Pos.) m/z calc’d for C29H24F3NOP 







(R)-4-Benzhydryl-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole.  White 
amorphous solid; Rf = 0.45 (hexanes/EtOAc, 5/1); 1H NMR (300 MHz, CDCl3) δ 7.79 (m, 
1H), 7.38-7.13 (m, 22H), 6.88 (m, 1H), 4.92 (q, J = 9.0 Hz, 1H), 4.13 (dd, J = 9.3, 9.0 Hz, 
1H), 3.79 (t, J = 9.0 Hz, 1H), 3.72 (d, J = 9.0 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 164.2, 142.2, 142.1, 138.8 (d, JCP = 25 Hz), 138.0-137.7 (3 lines), 134.1 (d, JCP 
= 21 Hz), 133.9 (d, JCP = 21 Hz), 133.7 (d, JCP = 2 Hz), 131.7 (d, JCP = 19 Hz), 130.5, 
130.0 (d, JCP = 3 Hz), 128.7-128.2 (9 lines), 128.0, 126.5, 126.2, 71.1, 70.1, 56.1; 31P 
NMR (121 MHz, CDCl3) δ -5.22; FTIR (Neat Film NaCl) 3056, 3026, 2895, 1649, 1598, 
1584, 1494, 1477, 1451, 1434, 1356, 1091, 1029, 909, 741 cm-1; HRMS (FAB, Pos.) m/z 



















Colorless viscous oil; Rf = 0.52 (hexanes/EtOAc, 5/1); 1H NMR (300 MHz, 
CDCl3) δ 7.89 (m, 1H), 7.40-7.28 (m, 13H), 6.92 (d, J = 1.8 Hz, 2H), 6.86 (m, 1H), 4.33 
(m, 1H), 4.00 (t, J = 8.7 Hz, 1H), 3.78 (dd, J = 8.7, 7.5 Hz, 1H), 2.95 (dd, J = 13.8, 4.2 
Hz, 1H), 2.01 (dd, J = 13.8, 10.2 Hz, 1H), 1.30 (s, 18H); 13C NMR (75 MHz, 
CDCl3) δ 163.9 (d, JCP = 3 Hz), 150.8, 138.9 (d, JCP = 25 Hz), 137.9 (d, JCP = 12 Hz), 
137.8 (d, JCP = 10 Hz), 137.2, 134.4 (d, JCP = 21 Hz), 134.0 (d, JCP = 21 Hz), 133.4 (d, JCP 
= 3 Hz), 131.5 (d, JCP = 17 Hz), 130.5, 130.0 (d, JCP = 3 Hz), 128.8-128.4 (6 lines), 127.9, 
123.3, 120.3, 71.6, 68.1, 41.6, 34.7, 31.5; 31P NMR (121 MHz, CDCl3) δ -3.60; FTIR 
(Neat Film NaCl) 2963, 1649, 1598, 1477, 1434, 1361, 1248, 1090, 1027, 965, 742, 696 
cm-1; HRMS (FAB, Pos.) m/z calc’d for C36H41NOP [M+H]+: 534.2926, found 534.2905; 







dihydrooxazole.  White amorphous solid; Rf = 0.38 (hexanes/EtOAc, 5/1); 1H NMR 
(300 MHz, CDCl3) δ 7.89 (m, 1H), 7.85 (m, 1H), 7.69 (m, 1H), 7.42-7.28 (m, 14H), 7.01 
(s, 1H), 6.88 (m, 1H), 4.54 (m, 1H), 4.14 (t, J = 8.4 Hz, 1H), 3.83 (dd, J = 8.4, 7.5 Hz, 
1H), 3.03 (ddd, J = 14.7, 5.4, 1.2 Hz, 1H), 2.40 (dd, J = 14.7, 9.0 Hz, 1H); 13C NMR (75 
MHz, CDCl3) δ 163.8 (d, JCP = 3 Hz), 140.2, 139.0-138.7 (3 lines), 137.9-137.8 (3 lines), 
134.4 (d, JCP = 21?Hz), 133.7 (d, JCP = 21 Hz), 133.6 (d, JCP = 2 Hz), 132.6, 131.3 (d, JCP 
= 18 Hz), 130.5, 129.9 (d, JCP = 2 Hz), 128.7-128.3 (6 lines), 127.9, 124.2, 123.8, 122.7, 
122.6, 121.5, 71.7, 66.0, 33.9; 31P NMR (121 MHz, CDCl3) δ -4.21; FTIR (Neat Film 
NaCl) 3054, 2963, 1651, 1585, 1476, 1434, 1356, 1252, 1216, 1090, 1026, 965, 749, 697 
cm-1; HRMS (FAB, Pos.) m/z calc’d for C30H25NOPS [M+H]+: 478.1394, found 














(S)-4-tert-Butyl-2-(2-(di-p-tolylphosphino)phenyl)-4,5-dihydrooxazole.  Colorless 
viscous oil; Rf = 0.39 (hexanes/EtOAc, 9/1); 1H NMR (300 MHz, CDCl3) δ 7.91 (ddd, J = 
7.5, 3.6, 1.5 Hz, 1H), 7.33 (m, 1H), 7.26 (m, 1H), 7.23-7.05 (m, 8H), 6.89 (ddd, J = 7.5, 
4.2, 1.5 Hz, 1H), 4.06 (dd, J = 10.2, 8.4 Hz, 1H), 3.98 (t, J = 8.3 Hz, 1H), 3.85 (dd, J = 
10.2, 7.8 Hz, 1H), 2.33 (s, 3H), 2.32 (s, 3H), 0.75 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 163.0 (d, JCP = 3 Hz), 139.3 (d, JCP = 25 Hz), 138.4, 138.1, 135.0-134.7 (4 lines), 
134.3 (d, JCP = 21 Hz), 133.9, 133.6 (d, JCP = 20 Hz), 131.9 (d, JCP = 20 Hz), 130.2, 129.9 
(d, JCP = 3 Hz), 129.2 (d, JCP = 7 Hz), 129.0 (d, JCP = 7 Hz), 127.8, 76.5, 68.3, 33.6, 25.7, 
21.3, 21.2; 31P NMR (121 MHz, CDCl3) δ -6.98; FTIR (Neat Film NaCl) 2953, 1653, 
1496, 1476, 1394, 1353, 1306, 1248, 1185, 1134, 1089, 1024, 967, 805, 743 cm-1; HRMS 









dihydrooxazole.  White amorphous powder; Rf = 0.44 (hexanes/EtOAc, 9/1); 1H NMR 
(300 MHz, CDCl3) δ 8.00 (ddd, J = 7.5, 3.9, 1.2 Hz, 1H), 7.62-7.50 (m, 4H), 7.44 (m, 
1H), 7.40-7.28 (m, 5H), 6.82 (ddd, J = 7.5, 3.9, 0.9 Hz, 1H), 4.20 (dd, J = 10.2, 8.4 Hz, 
1H), 4.06 (t, J = 8.4 Hz, 1H), 3.93 (dd, J = 10.2, 8.4 Hz, 1H), 0.69 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 161.8 (d, JCP = 3 Hz), 143.4-143.2 (m), 136.7 (d, JCP = 24 Hz), 134.4 (d, 
JCP = 21 Hz), 134.2, 133.7 (d, JCP = 20 Hz), 132.0 (d, JCP = 20 Hz), 130.74, 130.65 (q, JCF 
= 32 Hz), 130.5 (q, JCF = 32 Hz), 129.9 (d, JCP = 3 Hz), 128.9, 125.3-124.9 (m), 124.1 (q, 
JCF = 271 Hz,), 77.0, 68.4, 33.6, 25.6; 31P NMR (121 MHz, CDCl3) δ -7.29; 19F NMR 
(282 MHz, CDCl3) δ -63.23, -63.28; FTIR (Neat Film NaCl) 2958, 1653, 1606, 1480, 
1396, 1324, 1166, 1128, 1106, 1061, 1017, 831, 700 cm-1; HRMS (EI) m/z calc’d for 















White amorphous powder; Rf = 0.61 (hexanes/EtOAc, 3/1); 1H NMR (300 MHz, 
CDCl3) δ 7.48 (t, J = 2.9 Hz, 1H), 7.34-7.18 (m, 10H), 6.84 (ddd, J = 8.7, 2.4, 0.6 Hz, 
1H), 6.78 (ddd, J = 8.7, 3.3, 0.6 Hz, 1H), 4.13 (dd, J = 10.2, 8.4 Hz, 1H), 4.03 (t, J = 8.1 
Hz, 1H), 3.92 (dd, J = 10.2, 8.1 Hz, 1H), 3.82 (s, 3H), 0.73 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 162.5 (d, JCP = 3 Hz), 159.4, 139.0 (d, JCP = 13 Hz), 138.7 (d, JCP = 10 Hz), 
135.8, 134.1 (d, JCP = 20 Hz), 133.41 (d, JCP = 33 Hz), 133.36 (d, JCP = 20 Hz), 129.3 (d, 
JCP = 22 Hz), 128.3-128.0 (6 lines), 116.5, 114.9 (d, JCP = 4 Hz), 76.7, 68.3, 55.3, 33.6, 
25.7; 31P NMR (121 MHz, CDCl3) δ -10.12; FTIR (Neat Film NaCl) 3069, 2956, 2903, 
1654, 1594, 1561, 1479, 1434, 1354, 1336, 1297, 1224, 1181, 1093, 1050, 1022, 973, 744, 
697 cm-1; HRMS (EI) m/z calc’d for C26H28NO2P [M+]: 417.1858, found 417.1844; [α]25D 










4,5-dihydrooxazole.  White amorphous powder; Rf = 0.43 (hexanes/EtOAc, 9/1); 1H 
NMR (300 MHz, CDCl3) δ 7.60-7.50 (m, 5H), 7.40-7.26 (m, 4H), 6.89 (dd, J = 8.4, 3.0 
Hz, 1H), 6.74 (dd, J = 8.4, 3.6 Hz, 1H), 4.23 (dd, J = 10.2, 8.4 Hz, 1H), 4.08 (t, J = 8.4 
Hz, 1H), 3.96 (dd, J = 10.2, 8.4 Hz, 1H), 3.85 (s, 3H), 0.69 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 161.7 (d, JCP = 3 Hz), 160.0, 143.9-143.6 (3 lines), 135.9, 134.2 (d, JCP = 21 Hz), 
133.6 (d, JCP = 21 Hz), 130.5 (q, JCF = 32 Hz), 130.3 (q, JCF = 32 Hz), 127.1 (d, JCP = 21 
Hz), 125.2-124.8 (7 lines), 124.1 (q, JCF = 270 Hz), 116.7, 115.1 (d, JCP = 4 Hz), 77.0 (d, 
JCP = 1 Hz), 68.4, 55.4, 33.6, 25.6; 31P NMR (121 MHz, CDCl3) δ -13.06; 19F NMR (282 
MHz, CDCl3) δ -63.20, -63.24; FTIR (Neat Film NaCl) 2959, 2870, 1652, 1595, 1563, 
1485, 1396, 1322, 1226, 1166, 1127, 1106, 1061, 1017, 973, 909, 832, 735, 700 cm-1; 
HRMS (FAB, Pos) m/z calc’d for C28H27F6NO2P [M+H]+: 554.1683, found 554.1659; 














dihydrooxazole.  White powder; mp 98-100 ºC; Rf = 0.45 (hexanes/EtOAc, 9/1); 1H 
NMR (300 MHz, CDCl3) δ 8.20 (m, 1H), 7.51 (dd, J = 8.1, 1.8 Hz, 1H), 7.38-7.18 (m, 
10H), 6.99 (dd, J = 8.1, 3.3 Hz, 1H), 4.12 (dd, J = 10.2, 8.4 Hz, 1H), 4.03 (t, J = 8.4 Hz, 
1H), 3.90 (dd, J = 10.2, 8.4 Hz, 1H), 0.72 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 161.4 (d, 
JCP = 3 Hz), 144.2 (d, JCP = 30 Hz), 137.7 (d, JCP = 12 Hz), 137.3 (d, JCP = 9 Hz), 134.6, 
134.3 (d, JCP = 21 Hz), 133.6 (d, JCP = 20 Hz), 132.2 (d, JCP = 19 Hz), 130.1 (q, JCF = 33 
Hz), 128.9-128.4 (6 lines), 126.6-126.3 (m), 123.7 (q, JCF = 271 Hz), 77.0 (d, JCP = 1 Hz), 
68.4, 33.6, 25.7; 31P NMR (121 MHz, CDCl3) δ -6.55 (JPF = 2 Hz); 19F NMR (282 MHz, 
CDCl3) δ -63.36; FTIR (Neat Film NaCl) 3071, 2957, 1655, 1478, 1434, 1407, 1357, 
1343, 1326, 1302, 1262, 1244, 1174, 1131, 1080, 969, 744, 696 cm-1; HRMS (EI) m/z 










tert-butyl-4,5-dihydrooxazole.  White amorphous powder; Rf = 0.63 (hexanes/EtOAc, 
9/1); 1H NMR (300 MHz, CDCl3) δ 8.26 (m, 1H), 7.64-7.54 (m, 5H), 7.39-7.27 (m, 4H), 
6.95 (dd, J = 7.8, 3.0 Hz, 1H), 4.25 (dd, J = 10.2, 8.7 Hz, 1H), 4.09 (t, J = 8.7 Hz, 1H), 
3.95 (dd, J = 10.2, 8.7 Hz, 1H), 0.69 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 160.7 (d, JCP 
= 4 Hz), 142.6-141.7 (6 lines), 134.7-133.6 (5 lines), 132.4 (d, JCP = 20 Hz), 131.1 (q, JCF 
= 32 Hz), 130.9 (q, JCF = 32 Hz), 127.0 (q, JCF = 3 Hz), 126.7-126.4 (6 lines), 125.6-125.1 
(8 lines), 123.9 (q, JCF = 271 Hz), 123.5 (q, JCF = 271 Hz), 77.3 (d, JCP = 1 Hz), 68.6, 33.5, 
25.6; 31P NMR (121 MHz, CDCl3) δ -6.57; 19F NMR (282 MHz, CDCl3) δ -63.33, -63.39, 
-63.53; FTIR (Neat Film NaCl) 2960, 1657, 1606, 1479, 1397, 1324, 1169, 1129, 1107, 
1082, 1061, 1017, 832, 700 cm-1; HRMS (FAB, Pos) m/z calc’d for C28H24F9NOP 










76% yield  
 
[Cy2PH2]BF4.7  To a cooled (0 ºC) solution of Cy2PH (0.700 mL, 3.46 mmol, 1.00 
equiv) in Et2O (10 mL) was added HBF4 (54 wt% in Et2O, 0.386 mL, 5.19 mmol, 1.50 
equiv) in a dropwise fashion over 1 min.  During the addition, a white precipitate was 
formed.  After this, the ice-bath was removed and the reaction mixture was stirred for 15 
min at ambient temperature.  The resulting precipitate was collected by filtration, 
washed with dry Et2O (2 x 10 mL) and dried under vacuum to afford [Cy2PH2]BF4 (755 
mg, 2.63 mmol, 76% yield) as a white powder; mp 275 ºC (dec.); 1H NMR (300 MHz, 
CDCl3) δ 5.89 (dm, JHP = 482 Hz, 2H), 2.65 (m, 2H), 2.09 (m, 4H), 1.87 (m, 4H), 1.76 (m, 
2H), 1.68-1.20 (m, 10H); 13C NMR (75 MHz, CDCl3) δ 27.9 (d, JCP = 3.4 Hz), 25.8 (d, JCP 
= 42 Hz), 25.7 (d, JCP = 14 Hz), 24.8 (d, JCP = 1.4 Hz); 31P NMR (121 MHz, CDCl3) δ -
0.37; FTIR (KBr) 2932, 2858, 2231, 1452, 1061 cm-1. 
 
[i-Bu2PH2]BF4.  Prepared in an analogous manner to the previous entry.  White 
powder; mp 280 ºC (dec.); 1H NMR (300 MHz, CD3CN) δ 5.98 (dm, JHP = 496 Hz, 2H), 
2.30-2.15 (m, 4H), 2.07 (m, 2H), 1.07 (dd, JHH = 6.6 Hz, JHP = 1.5 Hz, 12H); 13C NMR 
(75 MHz, CD3CN) δ 25.8 (d, JCP = 4.8 Hz), 23.5 (d, JCP = 46 Hz), 23.2 (d, JCP = 11 Hz); 
31P NMR (121 MHz, CD3CN) δ -27.4; FTIR (KBr) 2965, 1471, 1393, 1084 cm-1. 
 
General Procedure for the Copper Catalyzed Synthesis of PHOX Ligands Utilizing 
a Dialkylphosphonium Salt 
 
N,N'-dimethylethylenediamine (87.5 mol%)















complex (SI3).  A flame-dried 50 mL Schlenk tube containing stir?bar was evacuated 
and refilled with dry nitrogen and then charged with [Cy2PH2]BF4 (538 mg, 1.88 mmol, 
1.88 equiv), anhydrous toluene (4.0 mL) followed by Cs2CO3 (1630 mg, 5.00 mmol, 5.00 
equiv). After 10 min of stirring, CuI (23.8 mg, 0.125 mmol, 0.125 eq.) and N,N’-
dimethylethylenediamine (93 µL, 0.875 mmol, 0.875 eq.) were added to the mixture and 
the resulting suspension was stirred for 10 min. To this was added SI2 (282 mg, 1.00 
mmol, 1.0 eq.) and toluene (4.0 mL) and the Schlenk tube was sealed and the reaction 
mixture was stirred at 110ºC until the complete consumption of the aryl bromide (27 h). 
The resulting reaction mixture was allowed to cool to 0 ºC, BH3-THF complex (1.0 M in 
THF, 3.0 mL, 3.00 mmol, 3.00 eq.) was slowly add to this mixture. After 2 h stirring at 
ambient temperature, the reaction was quenched by the addition of 20 mL of water and 
extracted with ether (20 mL x 2). The combined organic layers were washed with brine, 
dried over Na2SO4, filtered and concentrated under reduced pressure. The residual crude 
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oil was purified by flash SiO2 column (hexanes/EtOAc, 40/1) to afford 259 mg (63% 
yield) of desired borane complex SI3 as a white solid; mp 143-145 ºC; Rf = 0.52 
(hexanes/Et2O, 5/1); 1H NMR (300 MHz, CDCl3) δ 8.18 (m, 1H), 7.78 (m, 1H), 7.54-7.46 
(m, 2H), 4.41 (dd, J = 9.9, 8.1 Hz, 1H), 4.21 (dd, J = 9.9, 8.1 Hz, 1H), 4.10 (t, J = 9.9 Hz, 
1H), 2.83 (m, 1H), 2.57 (m, 1H), 1.98-1.74 (m, 4H), 1.74-1.55 (m, 6H), 1.32-1.10 (m, 
10H), 1.02 (s, 9H), 1.00-0.00 (br., 3H); 13C NMR (75 MHz, CDCl3) δ 163.1 (d, JCP = 2 
Hz), 138.2 (d, JCP = 15 Hz), 132.0, 130.7-130.2 (6 lines), 127.3 (d, JCP =43 Hz), 77.3, 68.6, 
33.7, 33.6 (d, JCP = 32 Hz), 33.5 (d, JCP = 32 Hz), 28.64, 28.55, 27.84, 27.78, 27.3 (d, JCP 
= 6 Hz), 27.1 (d, JCP = 6 Hz), 27.0, 26.9, 26.2, 25.78, 25.76; 31P?NMR (121 MHz, 
CDCl3) δ 38.22 (br d); FTIR (Neat Film NaCl) 2930, 2852, 2363, 2344, 1653, 1477, 1448, 
1364, 1332, 1305, 1246, 1100, 1063, 1037, 962, 760 cm-1; HRMS (EI) m/z calc’d for 
C25H40BNOP [M-H]+: 412.2941, found 412.2971; [α]24D = -5.6 (c 1.71, CHCl3). 
The phosphine-borane complex SI3 was recrystallized from hexanes to provide crystals 









Figure 1. ORTEP drawing of SI3 
 
Note: Crystallographic data have been deposited at the CCDC, 12 Union Road, Cambridge CB2 
1EZ, UK and copies can be obtained on request, free of charge, by quoting the publication 
citation and the deposition number 292036. 
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Table 1.  Crystal data and structure refinement for SI3 (CCDC 292036). 
Empirical formula  C25H41BNOP 
Formula weight  413.37 
Crystallization Solvent  Hexanes 
Crystal Habit  Blade 
Crystal size 0.33 x 0.30 x 0.12 mm3 
Crystal color  Colorless  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 20368 reflections used 
in lattice determination  2.13 to 27.97° 
Unit cell dimensions a = 10.5651(5) Å α= 88.9530(10)° 
 b = 19.0701(10) Å β= 87.6200(10)° 
 c = 24.3655(12) Å γ  = 85.2710(10)° 
Volume 4887.6(4) Å3 
Z 8 
Crystal system  Triclinic 
Space group  P1 
Density (calculated) 1.124 Mg/m3 
F(000) 1808 
Data collection program Bruker SMART v5.630 
θ range for data collection 1.67 to 28.47° 
Completeness to θ = 28.47° 90.0 %  
Index ranges -13 ≤ h ≤ 14, -24 ≤ k ≤ 25, -31 ≤ l ≤ 31 
Data collection scan type  ω scans at 5 φ settings 
Data reduction program  Bruker SAINT v6.45A 
Reflections collected 72958 
Independent reflections 43112 [Rint= 0.0534] 
Absorption coefficient 0.128 mm-1 
Absorption correction None 
Max. and min. transmission 0.9848 and 0.9590 
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Table 1 (cont.) 
 Structure solution and Refinement  
Structure solution program  Bruker XS v6.12 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  Bruker XL v6.12 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 43112 / 3 / 2121 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 1.001 
Final R indices [I>2σ(I),  26848 reflections] R1 = 0.0512, wR2 = 0.0789 
R indices (all data) R1 = 0.0963, wR2 = 0.0881 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.001 
Average shift/error  0.000 
Absolute structure parameter -0.04(5) 
Largest diff. peak and hole 0.424 and -0.360 e.Å-3 
 Special Refinement Details  
This crystal has eight molecules in the unit cell, each of them distinct with respect to the torsion 
angles within the (4-tert-butyl-1,3-oxazolin-2-yl)phenyl ligand. These conformational difference are 
propagated to the cyclohexyl ligands as well.  An interesting feature in this figure is the fan-like positions 
of the eight oxygen atoms relative the more-or-less centralized position of the eight nitrogen atoms. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) 
are based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors?(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
  







complex.  Prepared in an analogous manner to the previous entry.  White powder; Rf = 
0.46 (hexanes/Et2O, 5/1); mp 44-46 ºC; 1H NMR (300 MHz, CDCl3) δ 8.28 (m, 1H), 7.85 
(m, 1H), 7.57-7.48 (m, 2H), 4.39 (dd, J = 9.6, 8.4 Hz, 1H), 4.21 (dd, J = 9.6, 8.4 Hz, 1H), 
4.10 (t, J = 9.6 Hz, 1H), 2.59 (m, 1H), 2.26 (m, 1H), 2.08-1.70 (m, 4H), 2.00-0.00 (br, 
3H), 1.00 (s, 9H), 0.97 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 6.9 Hz, 3H), 0.71 (d, J = 6.6 Hz, 
6H); 13C NMR (75 MHz, CDCl3) δ 162.8 (d, JCP = 2 Hz), 137.8 (d, JCP = 18 Hz), 132.0, 
130.95 (d, JCP = 3 Hz), 130.90, 130.6 (d, JCP = 13 Hz), 128.7 (d, JCP = 41 Hz), 77.2, 68.5, 
35.4 (d, JCP = 35 Hz), 34.5 (d, JCP = 35 Hz), 33.9, 26.1, 24.9 (d, JCP = 7 Hz), 24.8 (d, JCP = 
6 Hz), 24.6, 24.3 (d, JCP = 7 Hz), 24.1 (d, JCP = 7 Hz); 31P NMR (121 MHz, 
CDCl3) δ 18.77 (br d); FTIR (Neat film, NaCl) 2957, 2870, 2381, 1661, 1588, 1568, 1466, 
1366, 1335, 1247, 1103, 1064, 1038, 1025, 963, 819, 773, 735 cm-1; HRMS (EI) m/z 
calc’d for C21H36BNOP [M-H]+: 360.2628, found 360.2623; [α]25D = +8.9 (c 1.00, CHCl3). 
 















Molecular sieves 4Å (MS4Å) were heated to 180 ºC under vacuum for 24 h prior to use.  
A Schlenk tube equipped with a stir bar was flame-dried under vacuum and backfilled 
with dry nitrogen.  The Schlenk tube was charged with the phosphine-borane complex?
SI3 (40.0 mg, 0.0968 mmol), MS4Å (160 mg), THF (2 mL) and MeOH (1 mL).  The 
mixture was stirred at 70 ºC for 72 h.  After cooling, the resulting mixture was filtered 
through a plug of Celite under nitrogen and concentrated in vacuo.  The resulting 
residue was dissolved in ether, passed through a plug of silica gel under nitrogen and 
concentrated in vacuo to afford desired phosphine SI4 (36.8 mg, 0.0921 mmol, 95% 
yield) as a colorless oil, without further purification; Rf = 0.33 (hexanes/Et2O, 5/1); 1H 
NMR (300 MHz, CDCl3) δ 7.62 (m, 1H), 7.52 (m, 1H), 7.42-7.28 (m, 2H), 4.37 (dd, J = 
10.2, 8.1 Hz, 1H), 4.21 (t, J = 8.1 Hz, 1H), 4.08 (dd, J = 10.2, 8.1 Hz, 1H), 1.96-1.46 (m, 
12H), 1.34-1.04 (m, 10H), 0.98 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 165.0 (d, JCP = 2 
Hz), 136.8 (d, JCP = 29 Hz), 136.7 (d, JCP = 26 Hz), 132.6 (d, JCP = 3 Hz), 129.7 (d, JCP = 7 
Hz), 129.1, 128.2, 76.6, 68.7, 34.7?(d, JCP = 14 Hz), 34.4(d, JCP = 14 Hz), 34.0, 30.2-29.8 
(6 lines), 27.3-27.1 (6 lines), 26.40, 26.37, 26.2; 31P NMR (121 MHz, CDCl3) δ -4.92; 
FTIR (Neat film, NaCl) 2925, 2850, 1658, 1478, 1446, 1351, 1240, 1091, 1024, 966 cm-1; 
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HRMS (FAB, Pos.) m/z calc’d for C25H39NOP [M+H]+: 400.2769, found 400.2754; [α]24D 






(S)-4-tert-Butyl-2-(2-(diisobutylphosphino)phenyl)-4,5-dihydrooxazole.  Prepared in 
an analogous manner to the previous entry.  Colorless oil; Rf = 0.37 (hexanes/Et2O, 5/1); 
1H NMR (300 MHz, CDCl3) δ 7.65-7.53 (m, 2H), 7.42 (m, 1H), 7.33 (m, 1H), 4.39 (dd, J 
= 10.2, 8.4 Hz, 1H), 4.24 (t, J = 8.4 Hz, 1H), 4.09 (dd, J = 10.2, 8.4 Hz, 1H), 1.85-1.40 
(m, 6H), 1.00 (s, 9H), 0.96 (dd, JHH = 6.6 Hz, JHP = 2.4 Hz, 6H), 0.92 (dd, JHH = 6.3 Hz, 
JHP = 3.6 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 165.0 (d, JCP = 1 Hz), 140.5 (d, JCP = 25 
Hz), 135.5 (d, JCP = 30 Hz), 130.6 (d, JCP = 3 Hz), 129.9, 129.3 (d, JCP = 6 Hz), 128.2, 
76.7, 68.7, 40.1 (d, JCP = 14 Hz), 39.9 (d, JCP = 14 Hz), 33.9, 26.32 (d, JCP = 13 Hz), 26.27 
(d, JCP = 13 Hz), 26.1, 24.51 (d, JCP = 9 Hz), 24.46 (d, JCP = 8 Hz), 24.14 (d, JCP = 9 Hz), 
24.06 (d, JCP = 9 Hz); 31P NMR (121 MHz, CDCl3) δ -38.92? FTIR (Neat film, NaCl) 
2953, 2868, 1660, 1464, 1364, 1351, 1335, 1243, 1093, 1048, 967 cm-1; HRMS (FAB, 
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Table 2 Entry 5 and 6 Aryl Bromide 
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 31P NMR  
Ph2P N
O
Table 1 Entry 4 Product 
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1H NMR  
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O
Table 1 Entry 5 Product 
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Table 1 Entry 7 Product 
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1H NMR  
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O
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